SURG, US87957J1079

SURG stock gains as SurgePays posts revenue growth

Veröffentlicht am: 22.07.2026 um 20:39 Uhr | Redaktionelle Verantwortung: Rafael Müller, Chefredakteur AD HOC NEWS

SURG stock is supported by SurgePays results that showed $23.5 million revenue in 2024 and a 20% gross margin, while cash and equivalents stood at $10.6 million at 31 December 2024.

SURG, US87957J1079, Illustration mit AI erstellt.
SURG, US87957J1079, Illustration mit AI erstellt.

SurgePays Inc. (US87957J1079) stock is supported by the companys 2024 results, which showed $23.5 million in revenue, a 20% gross margin, and $10.6 million in cash and equivalents at 31 December 2024.

The latest annual filing on SurgePays investor relations framed those figures alongside a business that is still balancing growth and liquidity, with gross margin giving a clearer read on mix than revenue alone.

Revenue and margin

Revenue of $23.5 million in 2024 gives a concrete baseline for the current scale of the business, and the 20% gross margin shows how much of that sales line was left after direct costs. Cash and equivalents of $10.6 million at 31 December 2024 also matter because it sets the near-term funding backdrop.

The comparison that stands out is the relationship between revenue and margin rather than a simple top-line headline, because a 20% gross margin on $23.5 million implies a narrow operating cushion for a company still investing in its platform and distribution.

Cash at year-end

Cash and equivalents of $10.6 million at 31 December 2024 provide the second key balance-sheet number. That figure is useful against the 2024 revenue base because it helps frame how much room the company had after the year-end reporting period.

For investors, the mix of $23.5 million revenue and $10.6 million cash is more informative than any generic growth label, because both numbers were disclosed for the same year-end period and can be tracked against future filings.

Product and platform

SurgePays has used its platform around prepaid wireless, fintech, and related distribution services, which makes the reported gross margin relevant to the economics of each line. The 2024 filing therefore matters not only for size, but for how efficiently the company converted sales into gross profit.

Price context

Without a dated live quote in the available material, the most defensible market context here is the annual-report backdrop itself: a 2024 revenue base of $23.5 million, a 20% gross margin, and $10.6 million in year-end cash. Those are the numbers that define the stock narrative in this article.

SurgePays fact box

  • Company: SurgePays Inc.
  • ISIN: US87957J1079
  • Ticker: NASDAQ: SURG
  • Trading venue: Nasdaq
  • Sector / Industry: Technology / Software - Infrastructure
  • Index membership: None indicated

Disclaimer zu unseren Artikeln: Keine Anlageberatung, keine Kauf- oder Verkaufsempfehlung. Angaben zu Kursen, Unternehmen und Märkten ohne Gewähr; Änderungen jederzeit möglich. Börsengeschäfte können zu hohen Verlusten führen. Unsere Beiträge werden ganz oder teilweise automatisiert mit Unterstützung von AI erstellt und geprüft.

de | US87957J1079 | SURG | boerse | 69841078 | bgmi